Insider Trading & Ownership - Goddard Glenn

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Goddard Glenn
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-03
Sale
2024-01-05
4:49 pm
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
5,365$29.46$158,05340,585
(Direct)
View
2023-01-04
Sale
2023-01-06
5:23 pm
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
2,427$37.21$90,30915,404
(Direct)
View
2022-01-01
Sale
2022-03-03
7:38 pm
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
1,013$112.24$113,69936,677
(Direct)
View
2021-09-07
Sale
2021-09-09
5:38 pm
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
3,482$180.12$627,17812,451
(Direct)
View
2021-08-30
Sale
2021-09-01
7:30 pm
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
30,000$159.45$4,783,538122,550
(Direct)
View
2021-08-05
Sale
2021-08-06
6:17 pm
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
20,000$151.05$3,021,05670,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-01
Option Award
2024-03-05
4:10 pm
N/A
2034-02-28
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
69,944$0110,529
(Direct)
View
2024-01-01
Exercise
2024-01-03
5:28 pm
2024-01-01
2031-03-02
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
3,062$049,014
(Direct)
View
2023-03-01
Option Award
2023-03-03
5:20 pm
N/A
2033-02-28
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
66,318$081,722
(Direct)
View
2023-01-01
Exercise
2023-01-04
8:29 pm
2023-01-01
2031-03-02
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
3,062$023,957
(Direct)
View
2022-03-01
Option Award(A)
2022-03-04
9:04 pm
N/A
2032-02-28
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
18,600$018,600
(Direct)
View
2022-01-01
Exercise
2022-03-03
7:38 pm
2022-01-01
2031-03-02
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
3,062$036,677
(Direct)
View
2022-03-01
Option Award
2022-03-03
7:38 pm
N/A
2032-02-28
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
12,720$036,677
(Direct)
View
2021-09-07
Exercise
2021-09-09
5:38 pm
N/A
2028-12-17
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
3,482$012,451
(Direct)
View
2021-09-07
Exercise
2021-09-09
5:38 pm
N/A
N/A
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
3,482$14.5812,451
(Direct)
View
2021-08-30
Exercise
2021-09-01
7:30 pm
N/A
N/A
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
28,183$19.27122,550
(Direct)
View
2021-08-30
Exercise
2021-09-01
7:30 pm
N/A
2028-10-31
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
30,000$0122,550
(Direct)
View
2021-08-31
Exercise
2021-09-01
7:30 pm
N/A
N/A
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
1,817$14.58122,550
(Direct)
View
2021-08-05
Exercise
2021-08-06
6:17 pm
N/A
N/A
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
20,000$19.2770,000
(Direct)
View
2021-08-05
Exercise
2021-08-06
6:17 pm
N/A
2028-10-31
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
20,000$070,000
(Direct)
View
2021-03-03
Option Award
2021-03-05
5:49 pm
N/A
2031-03-02
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
85,750$085,750
(Direct)
View
2020-03-02
Option Award
2020-03-04
5:28 pm
N/A
2030-03-01
Intellia Therapeutics Inc.NTLAGoddard Glenn
EVP, Chief Financial Officer
125,000$0125,000
(Direct)
View
(A) Indicate amendment filing.